Articles About NASDAQ:MDVN
-
May 09, 2013Medivation Earnings: Here’s Why the Stock is Falling Now
Here's your Cheat Sheet to earnings...
-
May 09, 2013Medivation Earnings: Your Sneak Peek to the Big Announcement
Here's your Cheat Sheet to earnings...
-
March 26, 2013Will Dendreon Continue to Plummet?
Dendreon has performed poorly over the past year. Is this trend likely to continue?
-
March 04, 2013ExOne is an Outperform and 1 New Analyst Initiation to Note
Take a closer look at the new ratings and price targets...
-
March 02, 2013Medivation Earnings Call Nuggets: Gross to Net Conversion and the Pre-Chemo Market
What investors need to know...
-
March 01, 20133 New Analyst Research Notes Affecting These Stocks Now
Here's what analysts had to say about these companies today...
-
February 28, 2013
Medivation Earnings: Here’s Why the Stock is Down Now
Here's your Cheat Sheet to earnings...
-
February 04, 2013
Ingersoll-Rand Shows Potential for Margin Expansion and 3 Stock Analyses Sparking Chatter
Here's what analysts had to say about these companies today...
-
February 04, 2013
Elizabeth Arden Recommended a Buy on Volatility and 4 Stock Analyses Not to Miss
Here's what analysts had to say about these companies today...
-
January 23, 2013
Domino’s Pizza Target Increased and 4 Stock Analyses to Know Now
Here's why these stocks are moving now...
-
December 24, 2012
News Corp. Sees 16% Upside and 4 Stock Analyses Making Rounds
Here's what analysts had to say about these companies today...
-
December 11, 2012
MAKO Weakness Viewed as Buying Opportunity and 3 Stock Analyses Making Rounds
Here's what analysts had to say about these companies today...
-
November 15, 2012
Medivation Reiterated at Buy and 1 Reiterated Share to Note
Take a closer look at the new ratings and price targets...
-
October 03, 2012
Yahoo! Retains Neutral Rating and 4 Stock Analyses Not to Overlook
Here's what analysts had to say about these companies today...
-
September 30, 2012Dendreon: Will Expansion to Europe Boost Sales?
Difficulties still haunt the drug manufacturer as Provenge sells more slowly than expected...
Wall St. Cheat Sheet has been featured in these fine media outlets:
